1. Introduction {#sec0005}
===============

Early anxiety, even at subclinical levels, increases risk for clinically significant internalizing problems (i.e., anxiety and depressive disorders) in mid-childhood and into adult life ([@bib0005]; [@bib0010]; [@bib0015]; [@bib0020]). As a result, early detection and prevention efforts have been widely endorsed ([@bib0025]) but are limited by clinical screening methods that more accurately identify children who will *not* develop illness than those who will [@bib0020]; [@bib0030]). Furthermore, current assessment methods do not link to neural mechanisms and thus have limited utility in guiding the development of more effective intervention or prevention strategies ([@bib0035]). To address these issues, the Research Domain Criteria (RDoC) has been championed as a framework for linking symptoms (e.g., anxiety), across the normal to abnormal range, to neural circuits underlying constructs of relevance to psychopathology (e.g., cognitive control). RDoC posits that pinpointing associations between symptoms and neurobehavioral markers of psychologically relevant constructs will guide the design of novel strategies to treat and prevent psychopathology ([@bib0035]).

To realize this promise, candidate biomarkers of RDoC constructs and related neural circuits must be understood in the context of age and gender differences known to characterize psychopathology ([@bib0040]; [@bib0045]). For instance, the error-related negativity (ERN) is a neurophysiological marker of cognitive control associated with anxiety ([@bib0050]) that may differentially associate with anxiety symptom severity in children compared to adolescents and adults ([@bib0055]; [@bib0060]), and in women compared to men ([@bib0065]). Examining the effects of age and gender on ERN-anxiety associations in early childhood, when anxiety symptoms first present, represents an important step towards characterizing the ERN for developmentally informed application within the RDoC framework.

1.1. ERN as an RDoC biomarker associated with anxiety {#sec0010}
-----------------------------------------------------

The ERN is a negative deflection in the event-related brain potential (ERP) that occurs within 100 ms following an erroneous response ([@bib0070]), is typically maximal at frontocentral scalp locations, and is believed to be generated by anterior cingulate cortex (ACC), among other regions ([@bib0075]). Prominent theories suggest that the ERN may index error signaling to recruit cognitive control ([@bib0080]) and/or may reflect the rapid evaluation of the motivational significance of a mistake ([@bib0085]). These processes are of phenomenological relevance for anxiety given that worry and rumination may reflect an inability to recover from real life mistakes ([@bib0090]), and/or hypersensitivity to the importance of mistakes ([@bib0085]). The ERN has gained attention as an RDoC biomarker for anxiety disorders given that clinically-affected adolescents and adults, particularly those who experience high levels of anxious apprehension (i.e., worry), exhibit an enlarged ERN compared to healthy individuals ([@bib0050]; [@bib0095]; [@bib0100]). Indeed, consistent with the RDoC framework ([@bib0105]), the ERN tracks anxiety symptoms across the normal to abnormal range in community samples, with *larger* ERN relating to more anxiety symptoms from early adolescence into adulthood ([@bib0110]; [@bib0115]; [@bib0120]; [@bib0125]). While increased ERN amplitude has been most consistently associated with anxiety ([@bib0130]; [@bib0135]; [@bib0140]; [@bib0145]; [@bib0150]), some studies have also found increased ERN in relation to depression ([@bib0155]; [@bib0160]), whereas others show decreased ERN in depression ([@bib0085]; [@bib0165]; [@bib0170], [@bib0175]) or no relation between ERN and depressive symptoms ([@bib0110]).

1.2. ERN, anxiety and development {#sec0015}
---------------------------------

A gradual increase in ERN magnitude with age has been well-documented ([@bib0180]), but the influence of development on ERN-anxiety associations is less understood. When studied dimensionally in a community sample, greater anxiety was related to a larger ERN in older children (11--13 years), but to *a marginally (*i.e.*, trend-level-significant) smaller ERN* in younger children (8--10 years) ([@bib0185]), suggesting a reversal of the adult-like associations between anxiety symptoms and ERN in younger children. Consistent with this suggestion, higher levels of separation anxiety were related to a *smaller* ERN in a community sample of children ages 5--7 years ([@bib0190]). Moreover, Torpey and colleagues ([@bib0195]) found that fearful temperament at aged 3 was associated with a smaller ERN among 6-year-old children, but with a *larger* ERN when children were re-assessed at aged 9 ([@bib0200]). However, when anxiety was examined categorically, six-year-olds who met criteria for clinically significant anxiety demonstrated larger ERN compared to healthy children, consistent with the pattern of group differences observed when older patients are compared to healthy controls ([@bib0185]). Collectively, these findings raise the possibility that ERN-anxiety associations may shift with age *and* symptom severity in childhood ([@bib0055]; [@bib0060]([@bib0200]), and underscore the importance of examining the relationship between ERN and anxiety symptoms in young children across the full spectrum of severity.

1.3. Gender effects on the ERN and early expression of anxiety problems {#sec0020}
-----------------------------------------------------------------------

Converging lines of evidence suggest that characterization of the ERN as a developmentally sensitive biomarker of anxiety symptoms should consider interactive effects of age and gender. Not only is there evidence to suggest earlier maturation of the ERN in girls than boys ([@bib0205]) but anxiety problems are more common in females than males across the lifespan. It is well-documented that fear and anxiety affect more girls than boys beginning in childhood ([@bib0210]; [@bib0215]), and foreshadow higher rates of anxiety and depression in females compared to males from adolescence ([@bib0220]; [@bib0225]) into adulthood ([@bib0230]). The higher frequency of internalizing problems in females than males may be influenced by gender differences in neural circuitry ([@bib0235]). While it remains unknown whether the ERN indexes a process that is responsible for higher rates of anxiety disorders in females than males, recent meta-analytic evidence suggests that the association of larger ERN with anxiety in adulthood is characteristic of women, not men ([@bib0065]; [@bib0240]). Gender effects on the relation between ERN and anxiety symptoms have yet to be examined in children as a function of age.

1.4. The current study {#sec0025}
----------------------

The ERN has been previously posited as an RDoC-relevant biomarker of anxiety symptoms ([@bib0050]; [@bib0245]); but, despite the common emergence of anxiety in early to middle childhood ([@bib0230]) and developmental change in ERN magnitude during this period ([@bib0180]), the association between ERN and anxiety symptoms in young children is not well-characterized. Better understanding how ERN-anxiety associations shift with age, gender and symptom severity will be important for refining the ERN as an early biomarker of anxiety risk and potential treatment target. Thus, we sought to examine age *and* gender effects on the relationship between ERN and anxiety symptoms in children, ages four to nine, sampled across the non-clinical to clinical range of severity. Prior work has suggested a reversal of the adult pattern of ERN-anxiety associations at approximately age 10 years ([@bib0185]), however, neural networks for cognitive control ([@bib0180]) and behavioral capacity for this function ([@bib0250]) undergo dramatic development between early childhood and preadolescence. Thus, we tested for an age-related reversal in the association between ERN and anxiety between ages 4--9 years, remaining agnostic to precisely when this reversal might occur. In addition, based on findings from an adult meta-analysis ([@bib0065]), we hypothesized that the relationship of ERN with anxiety might be further moderated by gender such that ERN-anxiety associations would be stronger in girls than boys.

2. Method {#sec0030}
=========

2.1. Participants {#sec0035}
-----------------

Participants included 56 children (30 girls) sampled from the community and the University of Michigan Child and Adolescent Psychiatry Clinic to capture the full spectrum of anxiety symptoms severity. Participants were 6.87 years old on average (SD = 1.39, range = 4.1--9.7); 77% Caucasians, 5% African American, 16% bi-racial and 2% "Other". To be eligible for participation, children had to be between 4--9 years old and to have no history of head injury, serious medical illness, neurodevelopmental delay (autism spectrum disorder or mental retardation) and not taking medications that affect central nervous system functioning.

After data cleaning, the final sample consisted of 49 participants (26 girls; mean = 6.99 +/- 1.32 years, range 4.1--9.7). Six children (mean = 5.44 +/- .76 years, 4 girls) made fewer than six errors on the ERN-eliciting task and were excluded from further analysis based on standard convention ([@bib0255]). One additional child, whose ERN amplitude was more than three standard deviations from the mean, was excluded (age = 9.42; male). No differences with respect to age, gender and anxiety symptoms were found between children who were in the final sample compared to those excluded (all *p*s \> .05). The age distribution was comparable across gender (girls: mean age in years 6.63 +/- 1.11.; boys: mean age in years 7.31 +/- 1.43, t(47) = 1.82, *p* = n.s.).

Based on the effect size (partial r = .28) observed previously in a community sample of 55 children, 8- to 13-years old ([@bib0185]), power analysis conducted in G\*Power suggested a sample size of 75 is needed for detecting interactive effects of age x ERN on anxiety in that age group (with a power of .80). However, no prior developmental studies have investigated the relation between ERN and age on anxiety *in younger, preschool- to school-aged children* or *the moderating role of gender*, thus precluding direct comparison with the present study. Moreover, inclusion of anxious children recruited from a Child and Adolescent Psychiatry Clinic enabled sampling into the clinical range of anxiety severity (i.e., increased variance), distinguishing the sample presented here from prior work. Thus, analyses were conducted to test a priori hypotheses involving both age *and* gender effects on ERN-anxiety associations to generate preliminary results in the unique sample collected here.

2.2. Task {#sec0040}
---------

Participants performed the child-friendly Go/No-go "Zoo" task ([@bib0260]). In the Zoo task, children were asked to help a zookeeper return loose animals to their cages, except three friendly orangutans who are the zookeeper's "helpers" and should remain free. Children were asked to put the loose animals back in their cages by pressing a button as quickly as they could every time an animal picture was presented (Go Trials), but to withhold their response each time they saw an orangutan (No-Go trials). No-Go trials on the Zoo Task have been previously shown to produce error rates that are sufficient to elicit the ERN ([@bib0260]).

Children completed 8 blocks of the task, each including 30 Go trials and 10 No-Go trials for a total of 320 trials. For each trial, a fixation cross was presented for 200--300 milliseconds (ms), followed by an animal image presented for 750 ms, and a blank screen for 500 ms. Responses could be made during the animal image and blank screen presentation. Each block consisted of novel sets of animal images, balanced on color, animal type and size. The task was presented using Eprime software (Psychology Software Tools, Inc.: Pittsburg, PA). Before the experimental trials of the Zoo task, children practiced on a set of 12 trials, 3 with orangutans and 9 with other animals and could practice multiple times until they understood the task.

2.3. Procedure {#sec0045}
--------------

The study was approved by the University of Michigan Medical School Institutional Review Board. Initially, phone screening was conducted to determine that the child met study inclusion criteria. After written informed consent and oral assent were obtained from parents and children, respectively, children were brought to a child-friendly EEG booth by experimenters while parents filled out questionnaires. EEG experiments were conducted using the BioSemi ActiveTwo recording system (see below). Children were seated on a comfortable chair in front of a computer screen while watching cartoons during experimental set-up. To reduce fidgeting and increase compliance during ERP recording, children were given brief breaks between blocks and animal stickers as tokens for every block they completed. Verbal and visual feedback (in the form of a zoo map) were provided between blocks to remind children to stay still during blocks and monitor their progress through the zoo. Families received monetary incentives and children received toys for their participation.

2.4. Electrophysiological recording, data reduction and analysis {#sec0050}
----------------------------------------------------------------

The EEG was recorded from 34 Ag/AgCI scalp electrodes and two mastoid electrodes, using BioSemi ActiveTwo recording system. Electro-oculogram (EOG) data were recorded from electrodes placed above and below the right eye and at the outer canthi of both eyes to capture vertical EOG and horizontal EOG, respectively. Data were referenced to a ground formed from a common mode sense active electrode and driven right leg passive electrode (see [http://www.biosemi.com/faq/cms&drl](http://www.biosemi.com/faq/cms%26drl){#intr0005}.), and sampled at 1024 Hz. For analysis, EEG data were referenced to averaged mastoid electrodes, and band-pass filtered 0.05--30 Hz using zero-phase shift butterworth filters. EEG data were screened using automated algorithms that rejected epochs in which the absolute voltage range exceeded 500 u V for midline channels (Fz, FCz, Cz and Pz), consistent with prior work ([@bib0260]). Ocular movement artifacts were then corrected using a regression-based algorithm ([@bib0265]). After ocular correction, individual trials were rejected if any amplitudes were greater than 100 u V, differed by more than 50 u V from the previous time point, or were less than 0.5 μV in magnitude in any midline electrode.

### 2.4.1. Behavioral measures {#sec0055}

Correct trials included correct response to Go trials (button press when viewing any animal that was *not* an orangutan) and correct inhibition of response to No-Go trials (withholding button press to orangutan stimuli). Only the number of correct Go trials were evaluated. Errors were evaluated only for No-go trials, defined as errors of commission when children incorrectly responded to an orangutan ([@bib0260]). Response times were evaluated for correct Go trials.

### 2.4.2. ERP measures {#sec0060}

Response-locked ERP components were quantified using mean amplitude measurements relative to a pre-response baseline -200 to −100 ms, consistent with prior work in young children ([@bib0260]). The mean amplitude of the ERN was computed for commission errors in a window 0--50 ms after the incorrect button response on No-Go trials ([@bib0260]). ERN was measured at Fz (mean amplitude: -5.0 ± 5.1), FCz (mean amplitude: -5.4 ± 4.7) and Cz (mean amplitude: -3.6 ± 5.1). Overall amplitude at each of these locations was more negative on error relative to correct trials measured in the same time window (i.e., ERN effect, *p's* \< 0.001). As with prior work in this age group ([@bib0260]), ERN at FCz ([Fig. 1](#fig0005){ref-type="fig"}) had the highest mean amplitude and increased with age ([@bib0180]); thus, ERN measured at FCz was used in all subsequent analyses. When participants with higher numbers of errors were considered (e.g., \> 16), the split-half reliability of the ERN increased and was comparable with prior studies (e.g., Schroder et al., 2017). Importantly, main findings remained significant in secondary analysis of subjects who made more errors (e.g., \> 16) and therefore we report results with the full sample (\> 6 errors; N = 49) and provide sub-sample analyses (\> 16 errors; N = 33) in Supplementary Table 2.Fig. 1Panel A: ERN and CRN waveforms at FCz electrode. Panel B: ERN amplitude increased (more negative) with age.Fig. 1

### 2.4.3. Child anxiety symptoms {#sec0065}

Parent report, using the Child Behavior Checklist (CBCL/1-5 years and CBCL/6-18 years) ([@bib0270]), is commonly used to measure psychopathology in young children who struggle to provide accurate self-report ([@bib0275]). Thus, given the inclusion of the children as young as 4 years and the lack of validated self-report anxiety measures for children at this age ([@bib0280]; [@bib0285]), child anxiety was measured by parent report on the CBCL DSM-oriented Anxiety Problems subscale (CBCL-AP ; α = .79) ([@bib0290]) combined with the CBCL Somatic Problems (α = .64) subscale ([@bib0295]) by averaging the T-scores from the two subscales. The composite of these scales was used because young children often express anxiety as somatic complaints, and combination of the Anxiety and Somatic Problems subscales of the CBCL has been found to better capture anxiety severity than the CBCL-AP subscale alone ([@bib0295]). Moreover, the correlation between the two subscales were moderately high (r = .48, *p* =  .001) and reliability showed that the combined scale (with all the anxiety and somatic subscale items together) showed adequate reliability (α = .78). Of the 49 children who provided ERN data, CBCL data was missing for one (7.3-year-old boy), but was imputed using the Expectation-Maximization (EM) algorithm ([@bib0300]); therefore, the final sample remained 49 children.

### 2.4.4. Child depressive symptoms and attention problems {#sec0070}

Parent report on the DSM-oriented Depression Problems (α = .64) and Attention Problems (α = .76) subscales from the CBCL were also examined given prior work suggesting the ERN may be differentially modulated by these phenomena ([@bib0085]; [@bib0165]; [@bib0170]; [@bib0305]; [@bib0310]).

2.5. Data analysis plan {#sec0075}
-----------------------

All predictor variables were mean centered prior to the analyses. Pearson correlation was first conducted to examine inter-correlation among all study variables ([Table 1](#tbl0005){ref-type="table"}). Hayes' (2013) PROCESS (Model 3) was used to test for conditional effects of age and gender as moderators of the relation between ERN and child anxiety symptom severity. Specifically, the PROCESS model considered all two-way (Age X ERN, Gender X ERN, Age X Gender) and the three-way (Age X Gender X ERN) interactions as predictors of child anxiety symptoms. The main effect of age was treated as a continuous variable in the model.Table 1Descriptive statistic and Pearson correlation among all study variables.Table 1MeanSD12345671. Age6.991.32---2. \#Correct Go Trials231.598.94.45\*\*\*---3. Correct Go RT54465.9−.55\*\*\*−.45\*\*\*---4. \#NoGo Errors23.9811.4−.17−.32\*−.29\*---5. ERN−5.404.70−.34\*−.12.21.19---6. Anxiety53.635.21−.18.08−.09.00−.02---7. Depression53.375.19−.18−.03−.03−.03.11.67\*\*\*---8. Attention Prob.54.475.79−.09−.28.15−.05.09.38\*.51\*\*\*[^1]

Two additional PROCESS models (Model 3) were also conducted to test for conditional effects of age and gender on associations of ERN with child depressive and attention problems. To aid interpretation of results, linear regression was used to test for effects of age, gender and the interaction on behavioral measures; if not significant, the interaction term was dropped from the model. For comparison with prior work, effects of age, gender and performance on ERN were also assessed. Unstandardized beta coefficients were reported in all PROCESS and regression models.

3. Results {#sec0080}
==========

3.1. Behavioral {#sec0085}
---------------

Participants committed an average of 23.98 (SD = 11.40; range = 6--63) commission errors on 80 total No-Go trials, and responded correctly to 231.59 (SD = 8.94; range = 194--240) of 240 total Go trials. On No-go trials, the number of commission errors were fewer in girls than boys (M = 18.6; SD = 6.1 for girls, M = 30; SD = 13 for boys; *B* = -11.19, *p* = .000), but did not vary by age (*B =* -.36, *p =* .75). On Go trials, a greater number of correct trials (*B* = 2.88, *p =* .003) and faster response times (*B =* -29.51*, p =* .000) occurred with older age, but there was no effect of gender on either measure (number of correct Go trials: *B =* 1.47, *p =* .55; response times: *B =* 21.25*, p =* .20). There were no age X gender interactions on any measure of behavioral performance.

3.2. Age, gender and performance effects on ERN {#sec0090}
-----------------------------------------------

Consistent with prior work ([@bib0180]), older age associated with larger (i.e. more negative) ERN amplitude (*B* = -1.17, *p* =  .03, total *R*^2^ = .14; [Fig. 1](#fig0005){ref-type="fig"}), controlling for the effects of gender and performance. There were no significant gender or age X gender interaction effects on ERN amplitude (*p*s \> 0.05). Performance (i.e., number of No Go commission errors, number of correct Go trials and Go response time) did not associate with ERN amplitude ([Table 1](#tbl0005){ref-type="table"}) and there were no age X performance interaction effects on ERN amplitude (*p*s \> 0.05).

3.3. Differential relation of ERN with anxiety by age and gender {#sec0095}
----------------------------------------------------------------

As shown in [Table 2](#tbl0010){ref-type="table"}, there were no significant main effects of age, gender, ERN or two-way interaction terms as predictors of child anxiety symptoms (all *p* \>  .05). However, there was a significant 3-way interaction effect of Age X Gender X ERN on child anxiety symptoms (B = -.91, *p* =  .002) that explained 13% of the variance (*F* (1, 41) = 11.19, *p* = .002; effect size: partial r = .35; observed power = .92) in the model (total *R*^2^ = .24; *F* (7, 41) = 4.85, *p* = .0005).Table 2Regression predicting child's anxiety symptoms.Table 2Variables*BSE*Age−1.04.68Gender−2.971.68ERN.08.17Age X Gender.861.44Gender X ERN.59.36Age X ERN.05.13Age X Gender X ERN−.91\*\*.27*R*^2^.24*F*4.85\*\*\*[^2]

To explore the 3-way interaction on child anxiety, Johnson-Neyman (J-N) analyses were first conducted using PROCESS (Model 1) to characterize the conditional effects of age (in years) on the relationship of ERN with anxiety, separately for each gender. The J-N analysis for girls revealed a significant shift in the directionality of the ERN effect on anxiety between 7.2 and 8.6 years ([Fig. 2](#fig0010){ref-type="fig"}). There was no J-N significance region (or significance transition points) across the study age range (all *ps* \> .05) in boys. Next, based on the J-N defined age split, post-hoc simple slope analyses within PROCESS were conducted. Partial residuals from this analysis were plotted using the Visreg package in R to visualize how JN-defined age groups and gender moderate the relation of ERN and anxiety symptoms ([Fig. 3](#fig0015){ref-type="fig"}). As shown in [Fig. 3](#fig0015){ref-type="fig"}, smaller (i.e., less negative) ERN associated with more anxiety symptoms in younger girls (effect*=* .90, SE = .30, *p* =.004) whereas, in older girls, larger (i.e., more negative) ERN associated with more anxiety symptoms (effect = - .16, SE = .07, *p* = .03). In boys, ERN- anxiety associations were not significantly moderated by age (younger: effect = -.53, se = .42, *p* = .21; older: effect = -.13, se = .42, *p* = .74). Including the number of No go errors in the PROCESS models did not change primary results, and did not reveal any main effect of error rates. For comparison, Supplementary Fig. 1 plots raw data showing the ERN plotted against anxiety for each gender and age group.Fig. 2Johnson-Neyman analysis of the conditional effect of age on the relationship between ERN and anxiety severity in girls. \**p* \<  .05, +*p* \< .08.Fig. 2Fig. 3Plot of partial residuals (derived from post-hoc simple slope analyses within PROCESS) depicts how age and gender moderate the relation of ERN and anxiety symptoms. Expected values are presented as lines; confidence intervals are presented in gray band. n.s. = not significant.Fig. 3

Finally, there were no significant associations between any behavioral measures (number of correct trials or reaction time) and anxiety symptoms, and no two- or three-way interaction effects of any behavioral measure with age and/or gender on anxiety.

3.4. Relation of ERN with depression and attention problems by age and gender {#sec0100}
-----------------------------------------------------------------------------

No significant model was found for predictors of child depressive symptoms (*F* (1, 41) = 1.11, *p* = .37) and child attention problems (*F* (1, 41) = 1.29, *p* = .28).

4. Discussion {#sec0105}
=============

As operationalized in the RDoC framework ([@bib0105]), characterizing the neural circuits that relate to psychopathology should yield synergistic advances in the understanding and treatment of psychiatric illness, including anxiety ([@bib0315]). However, to realize this promise, converging lines of evidence suggest that effects of age and gender on neural circuits must be considered ([@bib0040]; [@bib0045]). Towards this end, the current study examined whether age and/or gender moderated the association between the ERN and anxiety in girls and boys, ages 4--9 years, when anxiety often first presents ([@bib0230]). Results support prior work implicating ERN as a neural correlate of anxiety in children ([@bib0145], [@bib0185]; [@bib0190]) and substantiate the possibility of an age-related reversal in the association of ERN and anxiety ([@bib0055]; [@bib0060]). Specifically, the adult-like pattern of larger ERN with greater anxiety severity ([@bib0100]; [@bib0125]; [@bib0245]; [@bib0320]; [@bib0325]; [@bib0330]) was observed in older girls, but reversed in younger girls in our sample. In contrast, there were no significant associations between the ERN and anxiety in younger or older boys, consistent with recent work showing ERN-anxiety association in women, but not men ([@bib0065]). These results suggest that the ERN-anxiety link is not only developmentally sensitive, but may also be gender specific. Thus, our findings highlight the importance of considering *both* age and gender differences known to characterize psychopathology when examining neural markers of RDoC constructs ([@bib0040]; [@bib0045]).

4.1. Cognitive control theory of ERN and anxiety {#sec0110}
------------------------------------------------

Cognitive control functions begin to develop in early childhood ([@bib0250]). Moreover, age-related change in cortical networks has been found to contribute to increased neural capacity for cognitive control ([@bib0335]; [@bib0340]; [@bib0345]; [@bib0350]). Accumulating evidence shows that, while neural networks that support cognitive control continue to mature from childhood into adolescence and early adulthood ([@bib0355]), key components of these networks (e.g., ACC), are already involved in the implementation of control functions in preschool-aged children ([@bib0360]). A widely accepted index of cognitive control, the ERN, occurs in response to errors, localizes to the ACC, *and* can be elicited as early as 3 years of age ([@bib0180]; [@bib0260]; [@bib0365]). Consistent with maturational trajectories for cognitive control, prior studies have found developmental increase in ERN amplitude from childhood ([@bib0370]) and throughout adolescence ([@bib0180]; [@bib0205]; [@bib0375]). Although we did not find a relationship between larger ERN and better performance (nor age moderation of this relationship) in the current study, likely due to insufficient power, prior work has found that age-related increases of ERN magnitude associates with faster RTs and higher accuracy ([@bib0370]). Taken together, this prior work suggests that the age-related increase in ERN amplitude may index the maturation of neural substrate for cognitive control, especially in performance monitoring of errors ([@bib0180]; [@bib0365] ([@bib0370]).

Cognitive control may play a key role in facilitating the inhibition and/or regulation of negative/threatening thoughts (i.e., rumination and worry) ([@bib0380]; [@bib0385]), and behavioral adaptation to reduce anxiety problems ([@bib0390]; [@bib0395]; [@bib0400]; [@bib0405]). The directional shift of the ERN-anxiety relationship from younger to older girls may therefore mark the developmental transition of increasing neural capacity of using ERN to signal the need for cognitive control ([@bib0060]), such that an enlarged ERN allows greater recruitment of cognitive control ([@bib0070]; [@bib0410]; [@bib0415]). In theory, low levels of ERN-indexed cognitive control in younger children may leave early anxiety symptoms unchecked, whereas the reversal of this relationship at older ages may reflect a compensatory process by which increasing neural capacity for cognitive control is leveraged to maintain adequate performance on task ([@bib0060]) and/or reduce anxiety symptom severity ([@bib0090]).

Notably, we found a significant relationship between ERN-anxiety problems in girls but not in boys. Our gender specific finding is consistent with a meta-analysis in adults showing the presence of ERN- anxiety problems in women, but not men ([@bib0065]). In epidemiologic work, anxiety disorders have been demonstrated to be more common in girls than boys from childhood, throughout adolescence and into adulthood ([@bib0215]; [@bib0220]; [@bib0230]). Indeed, it has been suggested that biological mechanisms for processing threat and anxiety-inducing stimuli may be more sensitive in girls than boys from the earliest stages of development ([@bib0420]; [@bib0425]). With a greater biological sensitivity to threatening stimuli, girls may have to recruit greater cognitive control (as indexed through ERN) to maintain task goals and/or reduce anxiety than boys. Therefore, the association of ERN with greater anxiety severity in girls (but not boys) may suggest that girls are more dependent on ERN-indexed ACC network to suppress sensitivity to and/or interference from anxiety.

On experimental tasks requiring cognitive control, girls exhibit better performance than boys (e.g., higher accuracy, fewer commission errors), consistent with the greater cognitive control capabilities that have been previously demonstrated in preschool-aged girls compared to boys ([@bib0430]). It is possible that ERN-indexed systems for cognitive control are more available to manage behavior, including behaviors related to fear and anxiety, in females than males over the course of development, which may be related to gender differences in the functional maturation of ACC ([@bib0435]; [@bib0440]). Further research, across a broader age range, is needed to understand whether the maturation of ACC influences the relationship between the ERN and anxiety symptoms and whether this relationship differs by gender.

4.2. Developmental transition of anxiety phenomenon and ERN {#sec0115}
-----------------------------------------------------------

We hypothesize that the developmental shift in ERN-anxiety relationship in girls may reflect a developmental change in neural capacity for cognitive control, however, other interpretations are possible. A larger ERN has been found to have a stronger association with worry/anxious apprehension than other forms (e.g., fear) of anxiety-related symptoms in meta-analysis ([@bib0100]). Some have argued that with the natural transition of anxiety phenomena from more fear-based disorders at younger ages (e.g. phobias) to worry-related disorders at older ages (e.g. generalized anxiety), a smaller ERN in younger, more anxious children may reflect sensitivity to acute, external threat (i.e., fear), whereas a larger ERN in older, anxious children may relate to the greater relevance of internal threat (i.e., worry ([@bib0055]; [@bib0085])). Thus, the shift of the ERN-anxiety relationship across ages may reflect the changing nature of anxiety symptom phenomenology with age ([@bib0055]; [@bib0200]).

Finally, it is important to note that although we do not find a significant ERN-anxiety link in boys, a non-significant pattern of larger ERN with greater anxiety severity was observed in younger boys (b = -.53, *p* = .21, see [Fig. 3](#fig0015){ref-type="fig"}). This pattern is consistent with previous work showing a larger ERN in clinically anxious compared to healthy 6-year-old children in a sample comprised of more boys (˜2/3) than girls (˜1/3) ([@bib0145]). It is possible that these previously reported findings were male-driven. Alternatively, ERN-anxiety association may also be influenced by anxiety severity (i.e., clinical vs subclinical) and further study in larger samples will be needed to understand whether age and gender effects on ERN-anxiety association shift with anxiety severity.

4.3. Limitations {#sec0120}
----------------

Our findings should be viewed with caution given our small sample size. Power analysis based on the effect size (partial r = .28) observed in prior work^37^ suggests that a sample size of 75 (power = .80) is needed to detect the interactive effect of age and ERN on anxiety in 8 - 13-year-old children. However, no prior developmental studies have investigated moderating effects of age *and* gender on ERN-anxiety relations among younger children, precluding direct comparison. In fact, in the current study, we observed a larger effect size (partial r = .35; observed power = .92) than previously reported ([@bib0185]), raising the possibility that a smaller sample may be appropriate when considering the interactive effects of age and gender on ERN-anxiety associations in preschool- to school-aged children (ages 4--9 years). On the other hand, small samples can produce statistically significant results that do *not* reflect a true effect due to outliers ([@bib0445]). Thus, even though we did not observe any outlier(s) driving the findings presented here, it is important to view our results as preliminary, requiring confirmation with a larger sample. Nonetheless, our results should guide future research to consider both age *and* gender when examining the ERN as a neurophysiological marker of anxiety in children.

Several other limitations deserve consideration. First, our study used a cross-sectional design and therefore is unable to infer longitudinal relationship or causality of ERN and anxiety symptoms. Second, our study relied on parent-report of anxiety symptoms as there is no validated self-report measure that reliably assesses anxiety symptoms in preschool-aged children. Third, we did not include a cognitive control measure outside of performance on the Go No Go task used to elicit the ERN. Further research that includes other behavioral measures of cognitive control is needed to more fully understand the relations among ERN, cognitive control and anxiety in children and to test the prediction that a smaller ERN may reflect less capacity for cognitive control in more anxious, younger girls (i.e., a 4-way interaction).

4.4. Conclusion {#sec0125}
---------------

Our findings represent an important first step towards clarifying the relation of the ERN and anxiety symptoms in children. If, as suggested by RDoC, indices of error-processing (e.g., ERN) in children with sub-clinical anxiety symptoms fall on a continuum between clinically affected children at one end and healthy children at the other, this information would justify future testing of strategies to shift ERN along the continuum to reduce subclinical symptoms and prevent the progression to illness. Specifically, cognitive control training or other interventions designed to *increase* ERN might help to reduce anxiety symptoms among preschool-aged girls. By contrast, given the opposite pattern of the ERN- anxiety relationship in school-aged girls, strategies to *decrease* ERN may hold more promise for anxiety symptom reduction ([@bib0450]). On the other hand, if greater ERN is an adaptive response to reduce anxiety, then interventions should be designed to increase ERN across early to late childhood and across genders. Future longitudinal work is needed to understand how changes in ERN associate with changes in anxiety symptoms *over time* and should consider age and gender to identify whether the ERN should be targeted differently in different children to reduce and prevent anxiety problems.
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[^1]: Note. RT is reaction time in millisecond. \#No Go Errors is the number commission errors on No Go trials. \*p \< .05, \*\*p \< .01, \*\*\*p \< .001.

[^2]: Note. \* *p* \<  .05, \*\* *p* \< .01, \*\*\* *p* \<  .001. Male gender is the reference group.
